Mayur Katkade

|US Regulatory| |CMC Regulated Market| |Complex Formulation| |IND| |ANDA (Inhalations, Nasal, Injectable, Ophthalmic, Oral Solution, OSD & Ointment)| |Life Cycle Management| |Query Response|

Role
Regulatory Generics Lifecycle and International Submissions (Rgli) - Coe Us Team at Sandoz
Location
Mumbai, MH, IN
LinkedIn followers
500 followers

About Mayur Katkade

NDAs, ANDAs, Biosimilar-351(k), INDs, Life Cycle Management and Query response: Complex…

Experience

  1. Regulatory Generics Lifecycle and International Submissions (Rgli) - Coe Us Team

    Sandoz

    Oct 2023 — Present · Maharashtra, IN

    US Scope -RGLI (Regulatory Generics Lifecycle and International Submissions:• Post approval submissions (PAS, CBE-30, CBE-0, Annual Reports).• Site Transfer Supplements.Query Responses (IR, DRL & CRL).• Working cross-functionally and collaborating with stakeholders/customers/CMO sites.• Change Controls evaluation and categorizations.

Skills

  • Regulatory Affairs
  • Actd Guidelines
  • Ctd
  • Dossier Preparation
  • Row
  • Dossier Compilation
  • Drug Regulatory Affairs
  • Regulatory Submissions
  • Regulatory Documentation
  • Regulatory Guidelines
  • Regulatory Filings
  • Usfda
  • New Drug Application (Nda)
  • Abbreviated New Drug Application (Anda)
  • Anda
  • Prefiling Anda
  • Post Approval Fillings
  • Prior Approval Supplement
  • Cbe 30, Cbe 0 & Annual Reports

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mayur Katkade — Regulatory Generics Lifecycle and International Submissions (Rgli) - Coe Us Team at Sandoz in Mumbai, MH, IN | Unifers